183 related articles for article (PubMed ID: 33178590)
1. Spectrum of Mesenchymal-Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis.
Li J; Hu K; Zhou L; Huang J; Zeng S; Xu Z; Yan Y
Front Oncol; 2020; 10():560615. PubMed ID: 33178590
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
Liu H; Zhang B; Sun Z
Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis.
Yi Q; Peng J; Xu Z; Liang Q; Cai Y; Peng B; He Q; Yan Y
Front Bioeng Biotechnol; 2022; 10():806851. PubMed ID: 35910024
[TBL] [Abstract][Full Text] [Related]
4. Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.
Zhou Z; Peng B; Li J; Gao K; Cai Y; Xu Z; Yan Y
Sci Rep; 2021 Sep; 11(1):18366. PubMed ID: 34526571
[TBL] [Abstract][Full Text] [Related]
5. A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers.
Li J; Hu K; Huang J; Zhou L; Yan Y; Xu Z
Front Oncol; 2021; 11():644854. PubMed ID: 33968743
[No Abstract] [Full Text] [Related]
6. Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.
Li J; Hu K; Huang J; Zhou L; Yan Y; Xu Z
Aging (Albany NY); 2021 Jun; 13(12):16541-16566. PubMed ID: 34160364
[TBL] [Abstract][Full Text] [Related]
7. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
9. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Zhang Z; Li L; Li M; Wang X
Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
[TBL] [Abstract][Full Text] [Related]
10. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
Li L; Feng Q; Wang X
Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.
Schrock AB; Frampton GM; Suh J; Chalmers ZR; Rosenzweig M; Erlich RL; Halmos B; Goldman J; Forde P; Leuenberger K; Peled N; Kalemkerian GP; Ross JS; Stephens PJ; Miller VA; Ali SM; Ou SH
J Thorac Oncol; 2016 Sep; 11(9):1493-502. PubMed ID: 27343443
[TBL] [Abstract][Full Text] [Related]
12. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis.
Long G; Hu K; Zhang X; Zhou L; Li J
Sci Rep; 2023 Mar; 13(1):4435. PubMed ID: 36932143
[TBL] [Abstract][Full Text] [Related]
14. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
15. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
16. Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer.
Liang T; Han L; Guo L
Comput Struct Biotechnol J; 2020; 18():1238-1248. PubMed ID: 32542110
[TBL] [Abstract][Full Text] [Related]
17. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
18. Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.
Cui J; Song Y; Han X; Hu J; Chen Y; Chen X; Xu X; Xing Y; Lu H; Cai L
Front Oncol; 2020; 10():542007. PubMed ID: 33123465
[No Abstract] [Full Text] [Related]
19. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Yan Y; Gao R; Trinh TLP; Grant MB
Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
[No Abstract] [Full Text] [Related]
20. New Insights Into PTBP3 in Human Cancers: Immune Cell Infiltration, TMB, MSI, PDCD1 and m6A Markers.
Fang Z; Li P; Li H; Chong W; Li L; Shang L; Li F
Front Pharmacol; 2022; 13():811338. PubMed ID: 35359851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
